Showing results (51-60 of 70) with videos related to
Sort By:
Pageof 7
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 5, 2014
Randomized phase III trial to test accelerated versus standard fractionation in combination with concurrent cisplatin for head and neck carcinomas in the Radiation Therapy Oncology Group 0129 trial: long-term report of efficacy and toxicityPhuc Felix Nguyen-Tan, Qiang Zhang, K Kian Ang, et al.International Journal of Radiation Oncology, Biology, Physics|October 12, 2016
Quality of Life and Performance Status From a Substudy Conducted Within a Prospective Phase 3 Randomized Trial of Concurrent Standard Radiation Versus Accelerated Radiation Plus Cisplatin for Locally Advanced Head and Neck Carcinoma: NRG Oncology RTOG 0129Canhua Xiao, Qiang Zhang, Phuc Felix Nguyen-Tân, et al.International Journal of Radiation Oncology, Biology, Physics|May 23, 2026
Defining the Role of SABR in Head and Neck Cancer: Results from a Multi-institutional Delphi ConsensusClaire Petit, Jack Phan, Sweet Ping Ng, et al.Oral Oncology|February 28, 2021
Risk groups of laryngeal cancer treated with chemoradiation according to nomogram scores - A pooled analysis of RTOG 0129 and 0522Musaddiq J Awan, Haley Gittleman, Jill Barnholtz-Sloan, et al.Oral Oncology|November 25, 2023
Gut microbiome predicts gastrointestinal toxicity outcomes from chemoradiation therapy in patients with head and neck squamous cell carcinomaCecilia Hes, Antoine Desilets, Marion Tonneau, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 18, 2019
Nomogram to Predict the Benefit of Intensive Treatment for Locoregionally Advanced Head and Neck CancerLoren K Mell, Hanjie Shen, Phuc Felix Nguyen-Tân, et al.Cancer|March 27, 2019
Validation of NRG oncology/RTOG-0129 risk groups for HPV-positive and HPV-negative oropharyngeal squamous cell cancer: Implications for risk-based therapeutic intensity trialsCarole Fakhry, Qiang Zhang, Maura L Gillison, et al.International Journal of Radiation Oncology, Biology, Physics|October 12, 2016
Quality of Life and Performance Status From a Substudy Conducted Within a Prospective Phase 3 Randomized Trial of Concurrent Accelerated Radiation Plus Cisplatin With or Without Cetuximab for Locally Advanced Head and Neck Carcinoma: NRG Oncology Radiation Therapy Oncology Group 0522Minh Tam Truong, Qiang Zhang, David I Rosenthal, et al.International Journal of Radiation Oncology, Biology, Physics|June 5, 2025
Long-Term Feeding Tube Use in Head and Neck Cancer Survivors-An Analysis of Patient- and Treatment-Related FactorsThomas J Galloway, Stephanie L Pugh, John A Ridge, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 5, 2017
Development and Validation of Nomograms Predictive of Overall and Progression-Free Survival in Patients With Oropharyngeal CancerCarole Fakhry, Qiang Zhang, Phuc Felix Nguyen-Tân, et al.Pageof 7